Who are the KOLs in the therapy area you are targeting?
What are their special interests? Where are they located?
How can you involve them? To date, you may have been given
a few names from your clinical team as a start. It is now
time to identify the 'movers and shakers' in your marketplace
and ensure that you begin working with them. PHASE II has
developed a rigorous five-stage program of early KOL development.
Identifying, profiling and working with the most influential
physicians within your target therapy area is an essential
prerequisite to commercial success with your new product.
KOL development today, for a return
tomorrow
(Click
to view)
|
|
|
